Asthma During Pregnancy - Topic Overview
continued...
Many women also have allergies, such as allergic rhinitis, along
with asthma. Treating allergies is an important part of asthma
management.
- Inhaled corticosteroids at recommended doses
are effective and can be used by pregnant women.
- The antihistamines
loratadine or cetirizine are recommended.
- If you are already taking
allergy shots, you may continue getting them, but
starting allergy shots during pregnancy is not recommended.
- Talk to
your health professional about using decongestants you take by mouth (oral
decongestants). There may be better treatment options.
A review of the animal and human studies on the effects of asthma
medications taken during pregnancy found few risks to the woman or her fetus.
It is safer for a pregnant woman with asthma to be treated with asthma
medications than for her to have asthma symptoms and asthma attacks.2 Poor control of asthma is a greater risk to the fetus than
asthma medications are.2 Budesonide is labeled by the
U.S. Food and Drug Administration (FDA) as the safest inhaled corticosteroid to
use during pregnancy. One study found that low-dose inhaled budesonide in
pregnant women seemed to be safe for the mother and the fetus.4
The following are recommendations from the U.S. National Asthma
Education and Prevention Program (NAEPP) for using asthma medications during
pregnancy.2
Recommendations for using asthma medicine
during pregnancy
| Severity |
Daily medicines needed to maintain
long-term control |
|
Severe persistent
|
Preferred:
- High-dose inhaled corticosteroid,
preferably budesonide AND
- Long-acting
inhaled beta2-agonist (such as salmeterol or formoterol) OR
- A combination medication that contains both a
high-dose corticosteroid and a long acting beta2-agonist (such as Advair
Diskus) AND IF NEEDED
- Corticosteroid tablets
or syrup long-term (2 mg/kg/day, generally do not exceed 60 mg/day). (Make
repeated attempts to reduce tablets or syrup, and maintain control with
high-dose inhaled corticosteroids.) Treatment by a specialist is recommended if
you are using oral corticosteroids long-term.
Alternative:
- High-dose inhaled corticosteroids,
preferably budesonide AND
- Sustained-release
theophylline to a serum concentration of 5 to 12 mcg/mL
|
|
Moderate persistent
|
Preferred:
-
EITHER low-dose inhaled
corticosteroids and long-acting inhaled beta2-agonists OR
- Medium-dose inhaled
corticosteroid
-
IF NEEDED in women with
recurring severe attacks, medium-dose inhaled corticosteroid and long-acting
inhaled beta2-agonist
Alternative:
- Low-dose inhaled corticosteroid and
either a leukotriene modifier (also called leukotriene receptor antagonist) or
theophylline (a methylxanthine)
- Medium-dose inhaled corticosteroid
and either a leukotriene modifier or theophylline, if needed
|
|
Mild persistent
|
Preferred:
- Low-dose inhaled corticosteroid,
preferably budesonide
Alternative:
- Cromolyn (mast cell stabilizer) or a
leukotriene modifier OR
- Sustained-release
theophylline to a serum concentration of 5 to 12 mcg/mL
|
|
Mild intermittent
|
- No daily medication
needed
- Short-acting bronchodilator for relief of symptoms that come
and go: 2 to 4 puffs short-acting inhaled beta2-agonists as needed for
symptoms. Albuterol is the preferred medication. If you are using albuterol
more than 2 days in each week, see your health professional for treatment of
mild persistent asthma.
- Severe episodes may occur, separated by long periods of
normal lung function and no symptoms. A course of corticosteroid tablets,
syrup, or injection is recommended for severe episodes.
|
|
Quick relief: All
patients
|
- Short-acting bronchodilator: 2 to 4
puffs short-acting inhaled beta2-agonist as needed for symptoms. Albuterol is
the preferred medication.
- Intensity of treatment will depend on
severity of attack; up to 3 treatments at 20-minute intervals or a single
nebulizer treatment as needed. Course of
corticosteroid tablets, syrup, or injection may be needed.
- Use of
short-acting beta2-agonists more than 2 times a week (except for exercise) or
more than 1 canister in 3 months may indicate the need to start (or increase)
long-term control therapy.
|
Previous Page [1] [2] [3] Next Page